All Type of News
Calls growing for sale of OTC drugs at convenience stores
The Korea Chamber of Commerce and Industry (KCCI) said a majority of people support supermarket sales of OTC drugs.
According to a recent survey of 800 adults conducted by the Korea Chamber of Commerce and Industry...
Wholesalers’ woe over thin margin
Just as the pharmaceutical industry is feeling price and margin pressure, so are wholesalers in today’s healthcare marketplace.
The massive price-cut plan starting April will continue to pressure wholesaler profit ...
6 humidifier sterilizers shouldn’t be used: KCDC
The Korea Centers for Disease Control and Prevention issued a strong warning against the use of six sterilizers in home humidifiers yesterday, after its test results on mice showed that they suffered from the same pul...
Winners of the 13th Korea New Drug Award
The Korea Drug Research Association, under the sponsorship of the Ministry of Health and Welfare, Ministry of Knowledge Economy and the Ministry of Education, Science and Technology, will award two Korean companies wi...
Local drugmakers seeking to tackle falling revenue
A plethora of major issues are slated to affect Korean industries this year, including a massive price -cut plan starting April.
The forecast of rocky pharmaceutical markets could lead to uncertain financing condit...
CKD, Roche Korea forge partnership
Chong Kun Dang Pharmaceutical announced Tuesday that it has inked a business alliance agreement with Roche Korea.
Under the deal, CKD will be in charge of selling six Roche drugs using its extensive domestic distri...
Mvix S takes on Viagra, Cialis
SK Chemicals is enjoying brisk sales of its anti-impotence drug, Mvix S due to its new oral disintegrating film as a new dosage form.
The company said that the annual sales of Mvix S is expected to surge 30 billion...
LG Life Sciences targets 400 billion won in 2012 sales
LG Life Sciences aims to achieve 400 billion won in sales this year with the intention of emerging as one of research oriented companies, a company executive said Tuesday.
“We will reach 400 billion won in this yea...
New drug pricing policy squeezing drug firms
The government’s plan to cut drug prices by an average of 14 percent starting April has triggered vehement protests from the domestic pharmaceutical community.
A report released by the Korea Pharmaceutical Manufac...
Handok, Mitsubishi Tanabe announces licensing agreement for novel DPP-4 agent
Handok Pharma and Mitsubishi Tanabe Pharma announced Tuesday the execution of a license agreement granting Hanmi to market Mitsubishi Tanabe’s new dipeptidyl peptidase 4 (DPP-4 agent) MP-513 (teneligliptin) for the tr...
